Pharma Capsules - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharma Capsules

Pharmaceutical Technology


People
Cook, ABB, Tyco, and Mettler-Toledo Gain New Managment

Cook Pharmica (Bloomington, IN), the contract biopharmaceutical manufacturing division of Cook Medical, named Connie Degen vice-president of operations and Tedd Green vice-president of business operations and chief financial officer.

Degen will direct and oversee all activities of manufacturing, maintenance, manufacturing sciences, and engineering. Green will provide overall strategic leadership by overseeing Cook's fiscal, human resource, project management, business development, marketing programs, policies, and services.

ABB (Zurich, Switzerland) appointed Enrique Santacana as region manager, ABB North America and president and CEO of ABB Inc. USA. Most recently, he was ABB's region division manager for power products in North America.

Tyco International Ltd. (Princeton, NJ) appointed Patrick Decker president of Tyco Flow Control, a business segment of Tyco and provider of flow-control products. Decker joined Tyco in May 2003 as the chief financial officer of Tyco's plastics and adhesives business.

Robert Scott was named the new product manager for X-ray inspection at Mettler-Toledo Safeline (Tampa, FL). Scott will oversee the sale and commissioning of all X-ray units in the Americas.

Standards
US Pharmacopeia Lists EUDRAGIT Polymers

The US Pharmacopeia (Rockville, MD) plans to list monographs of Degussa's (Parsippany, NJ) "EUDRAGIT NE 30 D" and "EUDRAGIT E 100" acrylic polymers in its US Pharmacopeia–National Formulary (USP–NF) beginning Aug. 1. The monographs are titled "Ethyl Acrylate and Methyl Methacrylate Copolymer Dispersion" and "Amino Methacrylate Copolymer," respectively.

Collaboration
JRS Pharma and CoreRx to Develop Coprocessed APIs

JRS Pharma LP (Patterson, NY) and CoreRx Pharmaceuticals (Tampa, FL) signed a collaboration agreement, whereby CoreRx will conduct formulation and development work for drugs that have been coprocessed using JRS Pharma's "PROSOLV" technology. The agreement involves investigation of the performance and stability enhancement of generic drug candidates, including cardiovascular, anti-infectives, and anticancer therapies.

Envirotainer, Continental Offer Cold-Chain Services

Envirotainer (Stockholm, Sweden) and Continental Airlines Cargo (Houston, TX) signed a global contract to expand a product line featuring Envirotainer's temperature-controlled, air-cargo containers. The containers are designed as alternatives to traditional cooling methods such as foams and gel packs.

Environtainer recently announced it will focus solely on serving the pharmaceutical industry with various transport solutions, temperature-controlled systems, and cold-chain containers.

Expansion
Dow to Boost PEG Capacity

The Dow Chemical Company (Midland, MI) plans to increase production capacity for its solid-grad "Carbowax Sentry" polyethylene glycols (PEGs) at its St. Charles operations in Hahnville, Louisiana. The company is targeting an increase of about 30% before the end of 2008.

The company's PEG materials are produced in accordance with current good manufacturing practices regulations and meet requirements stated in the US Pharmacopeia–National Formulary, European Pharmacopoeia, and Food Chemicals Codex.

Acquisition
Clondalkin Group Acquires Keller Crescent


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here